Screening and prevention of hepatitis B virus reactivation during chemotherapy Journal Article


Authors: Ludwig, E.; Cohen, N.; Papanicolaou, G. A.; Seo, S. K.
Article Title: Screening and prevention of hepatitis B virus reactivation during chemotherapy
Abstract: The incidence of both hepatitis B virus infection and cancer is common. The use of immunosuppressive therapy in patients with hepatitis B virus can result in reactivation of hepatitis B virus, which can, in turn, lead to significant morbidity and mortality. © 2015, UBM Medica Healthcare Publications. All rights reserved.
Keywords: mortality; hepatitis b; liver function; nonhuman; solid tumor; rituximab; mass screening; hematopoietic stem cell transplantation; alanine aminotransferase; prophylaxis; virus load; hepatitis b virus; immunosuppressive treatment; virus reactivation; lamivudine; virus dna; randomized controlled trial (topic); entecavir; cd20 antibody; human; article; hepatitis b surface antigen
Journal Title: Oncology (Norwalk)
Volume: 29
Issue: 12
ISSN: 0890-9091
Publisher: C M P Medica LLC * The Oncology Group  
Date Published: 2015-12-01
Start Page: 937
End Page: 940, 943
Language: English
PROVIDER: scopus
PUBMED: 26676897
DOI/URL:
Notes: Article -- Export Date: 3 February 2016 -- Source: Scopus